Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC.
Wang Y, Zhang N, Xue J, Zhu C, Wang Y, Zhang L, Yang X, Wang H, Wang S, Chao J, Yang X, Zhao H.
Wang Y, et al. Among authors: wang h, wang s.
Front Immunol. 2023 Jan 17;14:1084843. doi: 10.3389/fimmu.2023.1084843. eCollection 2023.
Front Immunol. 2023.
PMID: 36733485
Free PMC article.